Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENDO-REAL: Letrozole co-treatment during ovarian stimulation in women with endometriosis undergoing IVF/ICSI
2025-524995-53-00Phase 4Authorised
- Sponsor
- UZ Brussel
- Start
- Sep 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of letrozole in hypofertility (2 arms), sponsored by UZ Brussel. Primary endpoint: Cumulative live birth per stimulation cycle. Planned start Sep 2026; status: authorised.
02
Drugs
letrozole
03
Conditions
hypofertility
Beyond the preview
Go deeper on 2025-524995-53-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524995-53-00.